MolecuLight technology makes the invisible enemy of wound care, visible to clinicians across the world.
Rachel Cunningham
LONDON–(BUSINESS WIRE)–Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:XTM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3
Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,2 and can help to guide wound sampling and debridement,1,5,6 monitor wound progression,2,3 improve patient engagement4,5 and simplify wound documentation.1
